Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
10938 | 1022 | 31.6 | 67% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
236 | 3 | ADENOSINE//NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS//ADENOSINE RECEPTORS | 48331 |
2798 | 2 | LEFLUNOMIDE//MIZORIBINE//DIHYDROOROTATE DEHYDROGENASE | 3097 |
10938 | 1 | TIAZOFURIN//IMPDH//BENZAMIDE RIBOSIDE | 1022 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | TIAZOFURIN | authKW | 1378888 | 6% | 77% | 60 |
2 | IMPDH | authKW | 582915 | 4% | 49% | 40 |
3 | BENZAMIDE RIBOSIDE | authKW | 468925 | 2% | 83% | 19 |
4 | IMP DEHYDROGENASE | authKW | 410904 | 3% | 49% | 28 |
5 | IMPDH INHIBITORS | authKW | 392461 | 2% | 77% | 17 |
6 | INOSINE MONOPHOSPHATE DEHYDROGENASE | authKW | 262965 | 2% | 35% | 25 |
7 | TIAZOFURIN ANALOGUES | authKW | 149382 | 0% | 100% | 5 |
8 | INOSINE 5 MONOPHOSPHATE DEHYDROGENASE | authKW | 148488 | 1% | 38% | 13 |
9 | IMP DEHYDROGENASE INHIBITOR | authKW | 124484 | 0% | 83% | 5 |
10 | NAD ANALOGUES | authKW | 97589 | 1% | 47% | 7 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Chemistry, Medicinal | 2538 | 15% | 0% | 156 |
2 | Biochemistry & Molecular Biology | 1615 | 35% | 0% | 358 |
3 | Oncology | 1080 | 18% | 0% | 188 |
4 | Chemistry, Organic | 621 | 13% | 0% | 128 |
5 | Pharmacology & Pharmacy | 471 | 15% | 0% | 151 |
6 | Biophysics | 203 | 6% | 0% | 63 |
7 | Medicine, Research & Experimental | 49 | 4% | 0% | 39 |
8 | Genetics & Heredity | 29 | 4% | 0% | 38 |
9 | Hematology | 28 | 2% | 0% | 25 |
10 | Cell Biology | 26 | 5% | 0% | 49 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MED EXPTL ONCOL | 44812 | 0% | 50% | 3 |
2 | 237 HIRANOMACHI CHUO KU | 29876 | 0% | 100% | 1 |
3 | AFMBUMR 6098 | 29876 | 0% | 100% | 1 |
4 | CANC TREATMENT CLIN PHARMACOL BRANCH | 29876 | 0% | 100% | 1 |
5 | CANC TREATMENTPEDIAT BRANCHBLDG 10 | 29876 | 0% | 100% | 1 |
6 | CHEM VRILLY RECH | 29876 | 0% | 100% | 1 |
7 | CLIN NUESTRA SENORA CONCEPT | 29876 | 0% | 100% | 1 |
8 | CNRSERT 5ENSCM | 29876 | 0% | 100% | 1 |
9 | EA267 | 29876 | 0% | 100% | 1 |
10 | ERT 5 | 29876 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ADVANCES IN ENZYME REGULATION | 61341 | 3% | 6% | 35 |
2 | NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS | 8726 | 4% | 1% | 37 |
3 | NUCLEOSIDES & NUCLEOTIDES | 4473 | 1% | 2% | 10 |
4 | CURRENT MEDICINAL CHEMISTRY | 3556 | 2% | 1% | 23 |
5 | JOURNAL OF MEDICINAL CHEMISTRY | 3147 | 5% | 0% | 48 |
6 | CANCER BIOCHEMISTRY BIOPHYSICS | 2919 | 1% | 2% | 6 |
7 | CANCER COMMUNICATIONS | 2630 | 0% | 3% | 3 |
8 | CANCER RESEARCH | 2003 | 5% | 0% | 52 |
9 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1749 | 4% | 0% | 39 |
10 | BIOCHEMICAL PHARMACOLOGY | 1137 | 3% | 0% | 27 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TIAZOFURIN | 1378888 | 6% | 77% | 60 | Search TIAZOFURIN | Search TIAZOFURIN |
2 | IMPDH | 582915 | 4% | 49% | 40 | Search IMPDH | Search IMPDH |
3 | BENZAMIDE RIBOSIDE | 468925 | 2% | 83% | 19 | Search BENZAMIDE+RIBOSIDE | Search BENZAMIDE+RIBOSIDE |
4 | IMP DEHYDROGENASE | 410904 | 3% | 49% | 28 | Search IMP+DEHYDROGENASE | Search IMP+DEHYDROGENASE |
5 | IMPDH INHIBITORS | 392461 | 2% | 77% | 17 | Search IMPDH+INHIBITORS | Search IMPDH+INHIBITORS |
6 | INOSINE MONOPHOSPHATE DEHYDROGENASE | 262965 | 2% | 35% | 25 | Search INOSINE+MONOPHOSPHATE+DEHYDROGENASE | Search INOSINE+MONOPHOSPHATE+DEHYDROGENASE |
7 | TIAZOFURIN ANALOGUES | 149382 | 0% | 100% | 5 | Search TIAZOFURIN+ANALOGUES | Search TIAZOFURIN+ANALOGUES |
8 | INOSINE 5 MONOPHOSPHATE DEHYDROGENASE | 148488 | 1% | 38% | 13 | Search INOSINE+5+MONOPHOSPHATE+DEHYDROGENASE | Search INOSINE+5+MONOPHOSPHATE+DEHYDROGENASE |
9 | IMP DEHYDROGENASE INHIBITOR | 124484 | 0% | 83% | 5 | Search IMP+DEHYDROGENASE+INHIBITOR | Search IMP+DEHYDROGENASE+INHIBITOR |
10 | NAD ANALOGUES | 97589 | 1% | 47% | 7 | Search NAD+ANALOGUES | Search NAD+ANALOGUES |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | HEDSTROM, L , (2009) IMP DEHYDROGENASE: STRUCTURE, MECHANISM, AND INHIBITION.CHEMICAL REVIEWS. VOL. 109. ISSUE 7. P. 2903 -2928 | 163 | 71% | 107 |
2 | CHEN, LQ , PANKIEWICZ, KW , (2007) RECENT DEVELOPMENT OF IMP DEHYDROGENASE INHIBITORS FOR THE TREATMENT OF CANCER.CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT. VOL. 10. ISSUE 4. P. 403-412 | 72 | 88% | 61 |
3 | PETRELLI, R , VITA, P , TORQUATI, I , FELCZAK, K , WILSON, DJ , FRANCHETTI, P , CAPPELLACCI, L , (2013) NOVEL INHIBITORS OF INOSINE MONOPHOSPHATE DEHYDROGENASE IN PATENT LITERATURE OF THE LAST DECADE.RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY. VOL. 8. ISSUE 2. P. 103-125 | 68 | 77% | 9 |
4 | MERINO, P , GHIRARDELLO, M , TEJERO, T , DELSO, I , MATUTE, R , (2014) RECENT ADVANCES ON THE ENANTIOSELECTIVE SYNTHESIS OF C-NUCLEOSIDES INHIBITORS OF INOSINE MONOPHOSPHATE DEHYDROGENASE (IMPDH).CURRENT TOPICS IN MEDICINAL CHEMISTRY. VOL. 14. ISSUE 10. P. 1212-1224 | 62 | 78% | 4 |
5 | BRAUN-SAND, SB , PEETZ, M , (2010) INOSINE MONOPHOSPHATE DEHYDROGENASE AS A TARGET FOR ANTIVIRAL, ANTICANCER, ANTIMICROBIAL AND IMMUNOSUPPRESSIVE THERAPEUTICS.FUTURE MEDICINAL CHEMISTRY. VOL. 2. ISSUE 1. P. 81 -92 | 61 | 70% | 13 |
6 | FRANCHETTI, P , GRIFANTINI, M , (1999) NUCLEOSIDE AND NON-NUCLEOSIDE IMP DEHYDROGENASE INHIBITORS AS ANTITUMOR AND ANTIVIRAL AGENTS.CURRENT MEDICINAL CHEMISTRY. VOL. 6. ISSUE 7. P. 599 -614 | 66 | 81% | 84 |
7 | PANKIEWICZ, KW , PATTERSON, SE , BLACK, PL , JAYARAM, HN , RISAL, D , GOLDSTEIN, BM , STUYVER, LJ , SCHINAZI, RF , (2004) COFACTOR MIMICS AS SELECTIVE INHIBITORS OF NAD-DEPENDENT INOSINE MONOPHOSPATE DEHYDROGENASE (IMPDH) - THE MAJOR THERAPEUTIC TARGET.CURRENT MEDICINAL CHEMISTRY. VOL. 11. ISSUE 7. P. 887-900 | 60 | 75% | 52 |
8 | GOLDSTEIN, BM , COLBY, TD , (1999) IMP DEHYDROGENASE: STRUCTURAL ASPECTS OF INHIBITOR BINDING.CURRENT MEDICINAL CHEMISTRY. VOL. 6. ISSUE 7. P. 519 -536 | 72 | 72% | 37 |
9 | BENTLEY, R , (2000) MYCOPHENOLIC ACID: A ONE HUNDRED YEAR ODYSSEY FROM ANTIBIOTIC TO IMMUNOSUPPRESSANT.CHEMICAL REVIEWS. VOL. 100. ISSUE 10. P. 3801 -3825 | 73 | 60% | 126 |
10 | CHOLEWINSKI, G , IWASZKIEWICZ-GRZES, D , PREJS, M , GLOWACKA, A , DZIERZBICKA, K , (2015) SYNTHESIS OF THE INOSINE 5 '-MONOPHOSPHATE DEHYDROGENASE (IMPDH) INHIBITORS.JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. VOL. 30. ISSUE 4. P. 550 -563 | 42 | 79% | 2 |
Classes with closest relation at Level 1 |